4 recalls found for CARVEDILOL. Check if any of your products are affected.
The FDA recalls 26,628 cartons of Carvedilol Tablets USP 12.5 mg distributed nationwide. The product fails CGMP standards due to NNCI impurity exceeding FDA limits. Stop using and contact The Harvard Drug Group LLC and Rugby Laboratories for guidance.
Glenmark Pharmaceuticals recalls 4,800 bottles of Carvedilol 25 mg tablets distributed nationwide in the USA. The recall cites CGMP deviations and a nitrosamine impurity exceeding the Acceptable Intake Level. Consumers should stop using the product and contact Glenmark or their healthcare provider for guidance.
Glenmark Pharmaceuticals Inc. recalls 44,328 bottles of Carvedilol tablets, 3.125 mg, distributed nationwide in the USA. The impurity N-nitroso carvedilol I exceeds the Acceptable Intake Level. Consumers should stop using the product and contact Glenmark for guidance.
Glenmark Pharmaceuticals recalls 14,976 bottles of Carvedilol 25 mg distributed nationwide in the United States after FDA-identified NNCI impurity exceeds limits. The impurity prompted CGMP deviation findings. Consumers should stop taking the drug and contact Glenmark or a healthcare provider for guidance.